Skip to main content
OpenTrials
Completed

NCT Number: NCT00543894

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A prospective, observational, multicenter study (ANTHICUS).

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with hospital-acquired infections and hospitalised in the ICU at one moment of their hospital stay
  • Hospital-acquired infections accounting for eligibility are:
  • nosocomial pneumonia (including ventilator-associated pneumonia)
  • bacteremia
  • intra-abdominal infections
  • urosepsis

Treatment and study plan

Secondary outcomes

  1. the frequency of appropriate antibiotic therapy (defined as the use of antibiotic(s) with "in vitro" efficacy against the identified pathogens responsible for the infection)

  2. the frequency of "the strategy of de-escalation" according to the culture results

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A Prospective, Observational, Multicenter Study (ANTHICUS)

Acronym: ANTHICUS

Important dates

Study start
2006
First posted
Oct 15, 2007
Registry last updated
Aug 12, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.